Improvement in underwriting performance attributed to a lower expense ratio and operational scale expansion, though the agency noted earnings remain reliant on investment returns to offset losses
The alleged IDR54bn (US$3.04m) investment fraud and payroll-related embezzlement could lead to further losses, weighing on the insurer's capital and profitability.
Strong distribution and regulatory expense controls lifted NBV in the first half of 2026, though the agency noted high equity exposure and a large single‑name stake heighten vulnerability to market vo...
Favourable underwriting in its core pet insurance portfolio drove 2026 results, though the agency noted the insurer’s small capital base leaves it exposed to volatility under stress
Stable underwriting results and a favourable loss ratio in the long-term line underpin the rating as the South Korean insurer pushes further into overseas specialty markets.
AM Best affirmed the ratings of Taiwan's second-largest non-life insurer, which made a net profit of NT$3.8bn (US$119.5m) in 2025 on a return on equity of 18.9%.
AM Best affirmed CBIC's A- ratings and still assesses its balance sheet as very strong, but a single concentrated unquoted stake pulled the insurer's capital adequacy score down and the outlooks with...
The Commonwealth Bank mandate that ended in January carried 44% of last year's premium, but Helia has held on to a lender contract it expected to lose.
